secwatch.observer — SEC 8-K summary
======================================

Issuer:     DT Cloud Star Acquisition Corp (DTSQ)
CIK:        0002017950
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001493152-25-025378
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

DT Cloud Star Acquisition appoints Dr. Xunyong Zhou as director
---------------------------------------------------------------

- Dr. Xunyong Zhou appointed as director effective November 26, 2025.
- Zhou, 50, has over 6 years of experience in biotechnology and health innovation, holds over 20 patents.
- He serves as director of Huakang Biomedical Holdings (HK: 08622) and chairman of Nanjing Hezhen Holding Group.
- Zhou holds a doctorate from Université Nice Sophia Antipolis and bachelor's from Tianjin University.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2017950/000149315225025378/0001493152-25-025378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2017950/000149315225025378/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer